Cargando…
Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials
An operationalized workflow paradigm is presented and validated with pilot subject data. This approach is reproducible with a high concordance rate between individual readers (kappa 0.73 [confidence interval 0.59–0.87; P=<0.0001]) using a 5-point scale to assess [(18)F] labeled fluorodeoxyglucose...
Autores principales: | Van Heertum, Ronald L, Scarimbolo, Robert, Wolodzko, John G, Klencke, Barbara, Messmann, Richard, Tunc, Feza, Sokol, Levi, Agarwal, Rajan, Strafaci, James A, O’Neal, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479259/ https://www.ncbi.nlm.nih.gov/pubmed/28670108 http://dx.doi.org/10.2147/DDDT.S136988 |
Ejemplares similares
-
Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
por: Van Heertum, Ronald L, et al.
Publicado: (2015) -
Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
por: Yoo, Kwai Han
Publicado: (2022) -
Una semana en Lugano
por: Hinojosa, Francisco
Publicado: (1994) -
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials
por: Kostakoglu, Lale, et al.
Publicado: (2023) -
Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)